menu
    • menu
    [{"orgOrder":0,"company":"SALIENT PHARMACEUTICALS INC","sponsor":"SALIENT PHARMACEUTICALS INC","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2013","type":"Inapplicable","leadProduct":"Calcium Aluminosilicate","moa":"Undisclosed","graph1":"Oncology","graph2":"Undisclosed","graph3":"SALIENT PHARMACEUTICALS INC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"SALIENT PHARMACEUTICALS INC \/ SALIENT PHARMACEUTICALS INC","highestDevelopmentStatusID":"1","companyTruncated":"SALIENT PHARMACEUTICALS INC \/ SALIENT PHARMACEUTICALS INC"},{"orgOrder":0,"company":"SALIENT PHARMACEUTICALS INC","sponsor":"Scott and White Hospital & Clinic | Texas A&M University","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2012","type":"Inapplicable","leadProduct":"Calcium Aluminosilicate","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase II","graph3":"SALIENT PHARMACEUTICALS INC","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"SALIENT PHARMACEUTICALS INC \/ Scott and White Hospital & Clinic | Texas A&M University","highestDevelopmentStatusID":"8","companyTruncated":"SALIENT PHARMACEUTICALS INC \/ Scott and White Hospital & Clinic | Texas A&M University"},{"orgOrder":0,"company":"SALIENT PHARMACEUTICALS INC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2012","type":"Inapplicable","leadProduct":"Calcium Aluminosilicate","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase I\/ Phase II","graph3":"SALIENT PHARMACEUTICALS INC","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"SALIENT PHARMACEUTICALS INC \/ Undisclosed","highestDevelopmentStatusID":"7","companyTruncated":"SALIENT PHARMACEUTICALS INC \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by SALIENT PHARMACEUTICALS INC

    Menu

    SALIENT PHARMACEUTICALS INC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            SALIENT PHARMACEUTICALS INC

                            U.S.A arrow
                            AllPack Indonesia
                            Not Confirmed

                            SALIENT PHARMACEUTICALS INC

                            U.S.A arrow
                            AllPack Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Calcium Aluminosilicate

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Recipient : MD Anderson Cancer Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            CASAD for Severe Diarrhea in the Emergency Department

                            Details : Calcium Aluminosilicate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            December 23, 2013

                            Lead Product(s) : Calcium Aluminosilicate

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Recipient : MD Anderson Cancer Center

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            SALIENT PHARMACEUTICALS INC

                            U.S.A arrow
                            AllPack Indonesia
                            Not Confirmed

                            SALIENT PHARMACEUTICALS INC

                            U.S.A arrow
                            AllPack Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Calcium Aluminosilicate

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase I/ Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

                            Details : CASAD (Calcium Aluminosilicate) is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Diarrhea.

                            Product Name : CASAD

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            December 03, 2012

                            Lead Product(s) : Calcium Aluminosilicate

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            SALIENT PHARMACEUTICALS INC

                            U.S.A arrow
                            AllPack Indonesia
                            Not Confirmed

                            SALIENT PHARMACEUTICALS INC

                            U.S.A arrow
                            AllPack Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Calcium Aluminosilicate

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase II

                            Sponsor : Scott and White Hospital & Clinic | Texas A&M University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infect...

                            Details : Calcium Aluminosilicate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Clostridium Difficile-associated Diarrhea.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            April 04, 2012

                            Lead Product(s) : Calcium Aluminosilicate

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase II

                            Sponsor : Scott and White Hospital & Clinic | Texas A&M University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth